Volume 82, Issue 6, Pages (September 2012)

Slides:



Advertisements
Similar presentations
Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction Shaun A. Summers, Poh-yi Gan, Lakshi Dewage,
Advertisements

Volume 78, Issue 12, Pages (December 2010)
Volume 65, Issue 1, Pages (January 2004)
Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells  B. Zhang, G. Ramesh, C.C. Norbury, W.B. Reeves 
Volume 83, Issue 5, Pages (May 2013)
Volume 77, Issue 6, Pages (March 2010)
The Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis  Rana Herro, Ricardo Da S. Antunes, Amelia R. Aguilera,
Volume 24, Issue 7, Pages (July 2016)
Volume 78, Issue 3, Pages (August 2010)
Plasmin is not protective in experimental renal interstitial fibrosis1
Volume 85, Issue 2, Pages (January 2014)
Volume 76, Issue 1, Pages (July 2009)
Volume 78, Issue 4, Pages (August 2010)
Volume 91, Issue 2, Pages (February 2017)
G.-T. Shin, D.R. Kim, J.-E. Lim, H. Yim, H. Kim  Kidney International 
Y.-H.H. Lien, K.-C. Yong, C. Cho, S. Igarashi, L.-W. Lai 
Volume 81, Issue 9, Pages (May 2012)
David J. Nikolic-Paterson, Shuang Wang, Hui Yao Lan 
Volume 78, Issue 12, Pages (December 2010)
Volume 67, Issue 3, Pages (March 2005)
Volume 84, Issue 2, Pages (August 2013)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 65, Issue 1, Pages (January 2004)
Volume 86, Issue 3, Pages (September 2014)
Volume 81, Issue 9, Pages (May 2012)
Volume 80, Issue 11, Pages (December 2011)
Volume 80, Issue 9, Pages (November 2011)
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Volume 61, Issue 1, Pages (January 2002)
Volume 58, Issue 2, Pages (August 2000)
Volume 70, Issue 7, Pages (October 2006)
Volume 69, Issue 1, Pages (January 2006)
Volume 54, Issue 1, Pages (July 1998)
Volume 80, Issue 10, Pages (November 2011)
Volume 59, Issue 4, Pages (April 2001)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Volume 81, Issue 3, Pages (February 2012)
Volume 81, Issue 9, Pages (May 2012)
Volume 84, Issue 5, Pages (November 2013)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Volume 60, Issue 2, Pages (August 2001)
Volume 57, Issue 3, Pages (March 2000)
Volume 70, Issue 10, Pages (November 2006)
Volume 86, Issue 4, Pages (October 2014)
Volume 73, Issue 12, Pages (June 2008)
Volume 92, Issue 3, Pages (September 2017)
Volume 64, Issue 3, Pages (September 2003)
Volume 76, Issue 5, Pages (September 2009)
Volume 84, Issue 4, Pages (October 2013)
Volume 77, Issue 4, Pages (February 2010)
Volume 85, Issue 2, Pages (January 2014)
Volume 75, Issue 6, Pages (March 2009)
Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill 
Volume 78, Issue 7, Pages (October 2010)
Volume 82, Issue 2, Pages (July 2012)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 56, Issue 2, Pages (August 1999)
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 67, Issue 6, Pages (June 2005)
CD4+ T cells: a potential player in renal fibrosis
Volume 54, Issue 1, Pages (July 1998)
Volume 58, Issue 5, Pages (November 2000)
Volume 76, Issue 8, Pages (October 2009)
Volume 59, Issue 6, Pages (June 2001)
Volume 84, Issue 1, Pages (July 2013)
Volume 21, Issue 2, Pages (February 2013)
Volume 88, Issue 6, Pages (December 2015)
Volume 70, Issue 9, Pages (November 2006)
Plasmin is not protective in experimental renal interstitial fibrosis1
Presentation transcript:

Volume 82, Issue 6, Pages 676-685 (September 2012) Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction  Shaun A. Summers, Poh-yi Gan, Lakshi Dewage, Frank T. Ma, Joshua D. Ooi, Kim M. O'Sullivan, David J. Nikolic-Paterson, A. Richard Kitching, Stephen R. Holdsworth  Kidney International  Volume 82, Issue 6, Pages 676-685 (September 2012) DOI: 10.1038/ki.2012.211 Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 1 Renal fibrosis is decreased in mast cell–deficient (KitW−sh/W−sh) mice. At 7 days after unilateral ureteric obstruction (UUO), there was less interstitial collagen deposition (a) in the kidneys of KitW-sh/W-sh mice (n=8) compared to (C57BL/6) wild-type (WT) mice (n=9). Photomicrographs of collagen deposition in WT and KitW-sh/W-sh mice after picrosirius red (PSR) staining are shown. Representative kidney sections visualized in color, viewed under polarized light, at original magnification × 400 in (b) WT and (c) KitW-sh/W-sh mice are shown, (d, e) in black and white, and (f, g) after NIH image analysis. The dotted line represents the mean collagen deposition in untreated WT mice. *P<0.05. Kidney International 2012 82, 676-685DOI: (10.1038/ki.2012.211) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 2 The deposition of α-smooth muscle actin (αSMA) is decreased in the absence of mast cells. (a) The deposition of αSMA was significantly decreased in the hydronephrotic kidneys of KitW-sh/W-sh mice (n=8) compared to the hydronephrotic kidneys of wild-type (WT) mice (n=9). Representative kidney sections demonstrating αSMA deposition in (b) WT and (c) KitW-sh/W-sh mice visualized in color, viewed under polarized light, (d, e) in black and white, and (f, g) after NIH image analysis are shown. In untreated WT mice, αSMA deposition was measured at <1%. All images are shown at original magnification × 400. *P<0.05. Kidney International 2012 82, 676-685DOI: (10.1038/ki.2012.211) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 3 Mast cells were present in the kidneys of hydronephrotic wild-type (WT) mice. (a) After toluidine blue staining, mast cells were seen in the lymph nodes of untreated WT mice at original magnification × 400, demonstrated by the arrow heads and in the white box (original magnification × 1200). (b) After fixation with methyl Carnoy's solution and staining with toluidine blue, mast cells were seen (occasionally) in the hydronephrotic kidneys of WT mice, 7 days after unilateral ureteric obstruction (UUO). At 7 days after UUO, chymase was detected in the hydronephrotic kidneys of WT mice (n=9), and the expression was normalized to 1 in the hydronephrotic kidney of WT mice. (c) Low levels of chymase expression were detected in the hydronephrotic kidneys of KitW-sh/W-sh mice (n=8). (d) Compared to untreated WT mice (n=6), mast cell activation and degranulation peaked after 6h (n=4) and then decreased, approaching baseline levels after 7 days (n=4). Subsequently, we labeled mast cells with a cell tracker and injected them into KitW-sh/W-sh mice (n=4). We then performed ureteric ligation and assessed mast cell accumulation 6h later. (e) Mast cells (green) were readily identified in the hydronephrotic kidneys, but were not seen in the (f) contralateral, control kidney, original magnification × 400. **P<0.01, ***P<0.001. Kidney International 2012 82, 676-685DOI: (10.1038/ki.2012.211) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 4 The expression and production of profibrotic markers were decreased in hydronephrotic kidneys from KitW-sh/W-sh mice. (a) At 7 days after unilateral ureteric obstruction (UUO), production of transforming growth factor-β (TGFβ) was highly significantly decreased in the hydronephrotic kidneys of KitW-sh/W-sh mice (n=8) compared to hydronephrotic wild-type (WT) kidneys (n=9). (b–d) Similarly, mRNA expression levels of TGFβ, α-smooth muscle actin (αSMA), and matrix metalloproteinase 12 (MMP12) were all decreased in the hydronephrotic kidneys of KitW-sh/W-sh mice compared to WT mice. (e–g) There was no difference in the MMP2, MMP3, or MMP9 kidney expression between the two experimental groups. The dotted line represents the mean value recorded in untreated WT mice. *P<0.05, ***P<0.001. Kidney International 2012 82, 676-685DOI: (10.1038/ki.2012.211) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 5 Chemokine expression and leukocyte recruitment was decreased in KitW-sh/W-sh mice. (a) Kidney expression of key monocyte (CCL5), CD4+ T cell (CXCL9, CXCL10, and CCL20) and neutrophil (CXCLR2) was decreased in KitW-sh/W-sh mice (n=8) compared to WT mice (n=9). There was a significant decrease in (b) interstitial macrophage and (c) CD4+ T cell recruitment in KitW-sh/W-sh mice, while (d) neutrophil recruitment was unchanged between the two experimental groups. *P<0.05, **P<0.01, ***P<0.001. Kidney International 2012 82, 676-685DOI: (10.1038/ki.2012.211) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 6 Renal fibrosis is decreased in mast cell–deficient (KitW-sh/W-sh) mice, 14 days after ureteric ligation. (a) Compared to wild-type (WT) mice (n=10), collagen deposition, assessed after picrosirius red staining and NIH image analysis, was decreased in KitW-sh/W-sh (n=9) mice. Representative images of fibrosis after NIH image analysis from WT and KitW-sh/W-sh mice are shown. (b) Kidney production and (c) expression of α-smooth muscle actin (αSMA) was also decreased in the absence of mast cells. *P<0.05, **P<0.01. Kidney International 2012 82, 676-685DOI: (10.1038/ki.2012.211) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 7 Mast cells promote renal fibrosis. To assess the direct pathogenicity of mast cells, we reconstituted KitW-sh/W-sh mice with bone marrow–derived mast cells from wild-type (WT) mice. When reconstitution was complete, after 12 weeks, we performed unilateral ureteric obstruction (UUO) on reconstituted KitW-sh/W-sh mice (n=7), and age-matched KitW-sh/W-sh mice (n=8) that were not reconstituted served as controls. We assessed renal fibrosis 7 days later. (a) Collagen deposition was increased in reconstituted KitW-sh/W-sh mice compared to control KitW-sh/W-sh mice. Representative photomicrographs of the hydronephrotic kidneys after PSR staining of (b, d) control KitW-sh/W-sh mice and (c, e) reconstituted KitW-sh/W-sh mice are shown in black and white and after NIH image analysis. (f, g) Kidney mRNA expression of TGFβ showed a trend of increase, while α-smooth muscle actin (αSMA) expression was highly significantly increased in the kidneys of reconstituted KitW-sh/W-sh mice. All images are shown at original magnification × 400. *P<0.05, ***P<0.001. Kidney International 2012 82, 676-685DOI: (10.1038/ki.2012.211) Copyright © 2012 International Society of Nephrology Terms and Conditions

Figure 8 Mast cell stabilization attenuated renal fibrosis. To assess the clinical effect of mast cell stabilization, we pre-emptively administered disodium chromoglycate (DSCG) (n=10) or control (sterile saline) (n=10) to wild-type (WT) mice and then performed unilateral ureteric obstruction (UUO). (a) Mice treated with DSCG had decreased collagen deposition in their kidneys. Representative kidney sections demonstrating collagen deposition in (b, d) control and (c, e) DSCG-treated mice are shown. Intrarenal mRNA expression of (f) TGFβ and (g) α-smooth muscle actin (αSMA) was decreased after treatment with DSCG. All images are shown at original magnification × 400. *P<0.05, **P<0.01. Kidney International 2012 82, 676-685DOI: (10.1038/ki.2012.211) Copyright © 2012 International Society of Nephrology Terms and Conditions